1-7 of 7
Kerstin M. Kampa, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FLT3 and KIT Isoforms Activate PI3K/AKT Signaling Which Is Potently Blocked by the Novel Dual PI3K/Mtor Inhibitors NVP-BEZ235 and NVP-BGT226.

Kerstin M Kampa, MD, Sandra Mueller, PhD, Katharina-Henriette Rasp, Lothar Kanz, MD, Michael C Heinrich, MD, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2009) 114 (22): 1740.
https://doi.org/10.1182/blood.V114.22.1740.1740
Published: 2009
Journal Articles

Insights Into the Role of ASPP2 (Apoptosis Stimulating Protein of p53-2) in Lymphomagenesis.

Kerstin M Kampa, MD, Sandra Mueller, PhD, Michael Bonin, PhD, Marcus M Schittenhelm, MD, Charles D Lopez, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1967.
https://doi.org/10.1182/blood.V114.22.1967.1967
Published: 2009
Journal Articles

KIT Inhibition Affects Heat Shock Protein (HSP) Activity: A Potential Rescue Mechanism towards KIT Tyrosine Kinase Inhibition and a Rationale for Dual KIT/HSP Inhibition.

Kerstin M Kampa, MD, Tanja Grandl, Sandra Mueller, Emmanuel Normant, PhD, Michael Walter, PhD, Wolfgang Schuetz, PhD, Lothar Kanz, MD, Michael C Heinrich, MD, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2009) 114 (22): 2753.
https://doi.org/10.1182/blood.V114.22.2753.2753
Published: 2009
Journal Articles

Iv Vitro Modeling of the Use of FLT3 Inhibitors To Reduce Chemotherapy Doses for Elderly Patients with AML.

Marcus M. Schittenhelm, MD, Kerstin M. Kampa, MD, Kevin W.H. Yee, MD, Lothar Kanz, MD,PhD, Michael C. Heinrich, MD,PhD
Journal: Blood
Blood (2007) 110 (11): 4213.
https://doi.org/10.1182/blood.V110.11.4213.4213
Published: 2007
Journal Articles

Tyrosine Kinase Inhibitors Only Partially Inhibit AKT-Dependent Signaling in Cells Expressing Oncogenic KIT, FLT3 or ABL Kinases. A Potential Model for Leukemia Cell Resistance to TKIs.

Marcus M. Schittenhelm, MD, Kerstin M. Kampa, MD, Sharon Shiraga, Lothar Kanz, MD, PhD, Michael C. Heinrich, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2370.
https://doi.org/10.1182/blood.V110.11.2370.2370
Published: 2007
Journal Articles

Apoptosis Stimulating Protein of p53 (ASPP2) Haploinsufficiency Promotes Irradiation-Induced High Grade Lymphomas in a Mouse Model.

Kerstin M. Kampa, MD, Jared D. Akoba, MD, Dexi Chen, MD, PhD, Kelly Beemer, MS, Joel Gay, Zhiyi Zhu, MS, Emerson Padiernos, BS, Christopher Corless, MD, PhD, Alexis Baily, William H. Flemming, MD, PhD, Charles D. Lopez, MD, PhD.
Journal: Blood
Blood (2007) 110 (11): 2639.
https://doi.org/10.1182/blood.V110.11.2639.2639
Published: 2007
Journal Articles

ASPP2 Haploinsufficiency Promotes Tumor Formation in a Mouse Model.

Kerstin M. Kampa, MD, Jared D. Acoba, M.D., Dexi Chen, M.D.,Ph.D., Kelly Beemer, M.S., Joel Gay, Zhiyi Zhu, M.S., Emerson Padiernos, B.S., Alice Fan, M.D., Dean Felsher, M.D.,Ph.D., Christopher Corless, M.D.,Ph.D., Louie Naumovski, M.D.,Ph.D., Charles D. Lopez, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4333.
https://doi.org/10.1182/blood.V108.11.4333.4333
Published: 2006